LONDON, Dec 21- Europe's medicines watchdog has launched a review of Merck& Co Inc's cholesterol drug Tredaptive after the medicine failed a U.S. trial assessing its effectiveness and safety. Although the commercial fallout from any decision to pull the drug from the market in Europe would be limited, it would be a blow to Merck's reputation.
BRUSSELS, Dec 20- Almost a thousand years since the Norman conquest made cider popular in Britain, brewers are launching cider invasions of their own, with the United States the main battlefield.
That includes firms such as Chicago- based biotech Novian Health, lured to a technology park outside Paris by generous tax credits for research and development. "For early-stage companies it's a really big plus because you can recoup a lot of your R&D expenses," Novian Health's Vice President Gene Bajorinas told Reuters. "
u f BC- CANADA- COLUMN/MARKETS 12-16 0818* Big catalyst for RIM remains the launch of its BB10 line* Investors will seek clues, new details on BlackBerry 10* Cash pile, subscriber numbers to draw attention* Downtrodden share price has doubled since Sept. 24. By Euan Rocha and Allison Martell.
TORONTO, Dec 13- A U.S. federal agency that recently ditched Research In Motion's BlackBerry in favor of the iPhone confirmed on Thursday it will trial RIM's new BB10 smartphones, fueling a fresh spurt in the Canadian company's share price ahead of the launch of the new devices.